Pharmacogenetics and Variability In Drug Exposure and Clinical Response to Corticosteroids in Severe BPD

Pharmacogenetics and Variability In Drug Exposure and Clinical Response to Corticosteroids in Severe BPD
Recruiting
1 years or below
All
Phase N/A
150 participants needed
1 Location

Brief description of study

This observational study will follow infants born with a gestational age of less than 32 weeks requiring positive pressure ventilation and planned clinical treatment with corticosteroids for bronchopulmonary dysplasia.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: bronchopulmonary dysplasia,BPD
  • Age: 1 years or below
  • Gender: All

Infants less than 32 weeks at birth Infants treated with corticosteroids for BPD (per neonatal attending clinical discretion) Receiving positive pressure ventilation (NIV, CPAP or endotracheal tube mediated assisted ventilation) Less than 14 days of age, <180 days of age

Updated on 04 Aug 2024. Study ID: 844677

Find a site

We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Preferred way of contact
Please provide your preferred way of contact
Race
Select race of your choice
Ethnicity
Select ethinicity
Other language

Interested in the study

Select a study center that’s convenient for you, and get in touch with the study team.

Contact a study center